Medical Affairs Launch Resourcing Benchmarks

STUDY OVERVIEW
BENCHMARK CLASS
SPECIAL OFFER

Non-members: Click here to review a complimentary excerpt from “Interweaving Medical Strategy to Maximize New Treatment Success: Medical Affairs Launch Resourcing Benchmarks”

STUDY OVERVIEW

Resource optimization is vital for Medical Affairs teams to maximize their impact on product launches and deliver measurable value throughout the product lifecycle. Efficient resourcing—whether through strategic staffing or precise budgeting—ensures that Medical Affairs functions align with organizational priorities while enabling successful market entry for new treatments.

Best Practices, LLC conducted this benchmarking research to equip Medical Affairs leaders with actionable insights into resource planning for launch success. This study examines optimal staffing models, budget allocation benchmarks, and proven strategies for overcoming critical challenges.

KEY TOPICS

Critical Challenges Impacting Launch Success
Budget Allocation for Medical Affairs Launch Excellence
Strategic Staffing for Medical Affairs Launch Optimization

KEY METRICS

Key challenges in executing an effective medical strategy for launch
Medical Affairs launch budget breakdown
Average Medical Affairs launch budget for novel therapies vs. therapies in crowded markets
Total Medical Affairs staffing levels and revenue per FTE – U.S. vs. Global breakdown
Average staffing levels per Medical Affairs sub-function
Medical FTEs dedicated to each sub-function for launch support
Projected Medical Affairs revenue per launch FTE – U.S. vs. Global comparison
Average launch staffing per Medical Affairs sub-function
Contribution of each Medical Affairs sub-function to the launch budget

SAMPLE KEY FINDINGS

Staffing for Launch: 70% of Medical FTEs are dedicated to launch, the bulk of which are field medical personnel.

METHODOLOGY

Best Practices, LLC engaged 18 Medical Affairs leaders driving launch, strategy, and operational excellence across top biopharma companies. Through benchmarking research and in-depth interviews with key benchmark partners, the study explores advanced insights and approaches for designing and implementing a successful medical launch strategy.

Industries Profiled:
Biotech; Pharmaceutical; Biopharmaceutical; Health Care; Clinical Research; Laboratories

Companies Profiled:
Chimerix; Corcept Therapeutics; Dermavant Sciences; Eisai; EMD Serono; Ferrer; Grifols; GlaxoSmithKline ; Galderma; Jazz Pharmaceuticals; KalVista Pharmaceuticals; Merz Aesthetics; OTSUKA; Sanofi; Santen; Takeda Pharmaceuticals; Vertex Pharmaceuticals; Zambon

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

Interweaving Medical Strategy to Maximize New Treatment Success: Medical Affairs Launch Resourcing Benchmarks

ID: 5841

Features:

Pages/Slides: 22

Published: 2024

Delivery Format: Online PDF Document

RELATED RESEARCH

1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
609E2A2014914E48000258BE80044B9C6
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-interweaving-medical-affairs-strategy-to-maximize-launch-success-resourcing-benchmarks?opendocument
18
19opendocument
2018.97.9.174
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB